Safety, Tolerability, and Biodistribution of [89Zr]Zr-DFO-APAC in Subjects With PAOD/CLI and Healthy Volunteers (Acronyms: 89Zr = Zirconium-89, DFO = Desferrioxamine, APAC = AntiPlatelet AntiCoagulant, PET/CT = Positron Emission Tomography/Computed Tomography)

Clinical trial NCT06204237 · RECRUITING

Trial details

NCT number: NCT06204237
Sponsor: Aplagon Oy
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Peripheral Arterial Occlusive Disease Critical Limb Ischemia

Start date: 2024-02-01
Primary completion: 2025-06-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.